HOUSTON — The American Society of Plastic Surgeons (ASPS), the world’s foremost authority on plastic and reconstructive surgery, has officially ushered in a new chapter of leadership. During "Plastic Surgery The Meeting"—the Society’s premier annual scientific conference held in Houston—Dr. Lynn A. Damitz, MD, FACS, was inaugurated as the organization’s new President. Her appointment marks a significant milestone for the 11,000-member organization, signaling a renewed focus on patient safety, data-driven outcomes, and the modernization of healthcare policy.
Dr. Damitz, a distinguished surgeon and academic, will serve a one-year term concluding on September 19, 2027. Her elevation to the presidency comes at a pivotal time for the medical community, as the specialty of plastic surgery faces the dual challenges of rapid technological innovation and evolving legislative landscapes regarding patient rights and insurance coverage.
The Core Mandate: Patient Safety and Data-Driven Excellence
In her inaugural address to the Society, Dr. Damitz emphasized that the mandate of the modern plastic surgeon is increasingly complex. "I am deeply honored to lead the American Society of Plastic Surgeons and represent our dedicated members worldwide," Dr. Damitz stated. "As plastic surgeons, our responsibility extends far beyond the four walls of the operating room. Patient safety must serve as the North Star for every decision we make—from the way we educate the next generation of surgeons to the way we integrate cutting-edge innovation into our practice."
Dr. Damitz’s platform is built on three central pillars: the rigorous application of quality metrics, the expansion of outcomes-based research, and the advancement of patient advocacy. By leveraging data, she aims to increase transparency and accountability across the entire spectrum of aesthetic and reconstructive procedures. Her goal is to ensure that ASPS remains the gold standard for clinical excellence, reinforcing the specialty’s role as a leader in healthcare innovation.
Chronology: A Career Built on Advocacy and Academic Rigor
The path to the presidency for Dr. Damitz has been defined by decades of tireless service to both her patients and the medical profession.
Early Foundations and Clinical Training
Dr. Damitz’s journey into medicine began at the Hahnemann University School of Medicine, where she earned her medical degree. Following her graduation, she gravitated toward the University of North Carolina (UNC) at Chapel Hill, where she completed her residency training in both general surgery and plastic surgery. This dual training provided her with a comprehensive understanding of complex trauma and oncologic reconstruction, which has remained a hallmark of her clinical practice. She further refined her skills through advanced fellowships in breast and aesthetic surgery, establishing her reputation as a surgeon capable of balancing high-stakes reconstruction with nuanced aesthetic artistry.
Rise Within the ASPS
Since becoming a member of the ASPS in 2002, Dr. Damitz has consistently occupied roles of increasing responsibility. Her leadership trajectory includes:
- 2002–Present: Active engagement in national committee work.
- Committee Leadership: Served as the Chair of the ASPS Membership Committee for three years, where she was instrumental in fostering professional development for younger surgeons.
- Board Level Influence: Served as ASPS Board Vice President of Health Policy and Advocacy, a role that positioned her at the forefront of national healthcare policy.
- The Presidency: Formally inaugurated in Houston, September 2024, to serve through 2027.
At the University of North Carolina School of Medicine, Dr. Damitz serves as the Chief of the Division of Plastic and Reconstructive Surgery, Director of Aesthetic Surgery, and Professor of Surgery. Her tenure at UNC has been characterized by a commitment to interdisciplinary collaboration, bridging the gap between oncologic surgery and reconstructive outcomes.
Supporting Data: The Impact of Policy Advocacy
Dr. Damitz’s reputation as a policy wonk is well-earned. During her tenure as Board Vice President of Health Policy and Advocacy, she was a central figure in efforts to modernize the Women’s Health and Cancer Rights Act (WHCRA). This landmark legislation is vital for patients undergoing mastectomies, as it guarantees coverage for breast reconstruction.
Her advocacy work has focused on closing the "access gap." Data from the ASPS suggests that patients often face significant hurdles when seeking reconstructive surgery due to varying state insurance mandates and outdated clinical definitions. By championing policy changes, Dr. Damitz has helped ensure that breast reconstruction is treated not as an elective luxury, but as a medically necessary component of cancer treatment.
Her work also extends to patients with congenital conditions. By lobbying for broader insurance coverage for developmental anomalies, she has helped improve the quality of life for pediatric patients, ensuring that the financial burden of surgery does not prevent access to life-changing care. Her ongoing participation in multidisciplinary initiatives focused on breast surgery quality underscores her belief that the best patient outcomes are achieved through standardized, evidence-based protocols.
Official Responses and Industry Sentiment
The response from the medical community to Dr. Damitz’s appointment has been overwhelmingly positive. Colleagues and industry leaders describe her as a "unifying force" who possesses the rare ability to bridge the gap between academic research and private clinical practice.
"Dr. Damitz represents the very best of our specialty," remarked a representative from the ASPS board. "Her ability to navigate the complexities of healthcare policy while maintaining a rigorous clinical standard makes her uniquely qualified to lead us through the current challenges facing plastic surgery. She understands that we are not just surgeons; we are advocates for the patients who rely on our expertise during some of the most vulnerable moments of their lives."
Dr. Damitz herself acknowledges that the presidency is a collaborative endeavor. "I look forward to supporting the work of board-certified plastic surgeons across the globe," she noted during her speech. "The strength of this society lies in our collective expertise. By fostering international partnerships and embracing innovation, we will continue to set the standard for what it means to be a provider of safe, transformative, and ethical care."
Implications: The Future of Plastic Surgery Under Damitz
As Dr. Damitz begins her term, the implications for the specialty are significant. Her leadership is expected to drive three major shifts:
1. The Rise of "Quality Metrics"
Under her direction, the ASPS is expected to expand its use of outcomes-based data. By requiring members to engage more deeply with registries and quality benchmarks, Dr. Damitz aims to create a "culture of transparency." This shift is intended to provide patients with more reliable information regarding surgeon performance and procedural risks, ultimately increasing trust in the board-certification process.
2. A Focus on Complex Reconstruction
While the public often associates plastic surgery with aesthetics, Dr. Damitz’s background in oncologic and trauma surgery serves as a reminder of the specialty’s core foundation. Her term will likely see increased funding and institutional support for research into complex reconstructive techniques, including microsurgery and nerve reconstruction, ensuring that plastic surgery remains a vital partner to other surgical specialties.
3. Strengthening International Alliances
Dr. Damitz has expressed a strong desire to expand the ASPS’s international footprint. By collaborating with global surgical societies, she aims to harmonize safety standards and education. This global approach is designed to ensure that patients everywhere—regardless of their geography—receive care that meets the stringent requirements of the American board-certified standard.
Conclusion: A Vision for Tomorrow
Dr. Lynn A. Damitz assumes the presidency of the American Society of Plastic Surgeons at a time when the discipline is undergoing a profound evolution. As technology advances and the public demand for both aesthetic and reconstructive procedures grows, the need for steady, principled, and forward-thinking leadership has never been greater.
Through her commitment to patient advocacy, her rigorous approach to clinical excellence, and her deep understanding of the intersection between medicine and policy, Dr. Damitz is well-positioned to guide the ASPS into a new era. As she takes the stage in Houston to lead the world’s largest organization of plastic surgeons, she carries with her the confidence of her peers and the promise of a specialty that is safer, more transparent, and more accessible than ever before.
For the patients whose lives are changed by the hands of a plastic surgeon, and for the surgeons who dedicate their lives to this craft, Dr. Damitz’s term represents a future where excellence is not merely an aspiration, but a consistent, data-driven reality. As she looks toward the next year and beyond, the message from the ASPS is clear: the future of plastic surgery is in capable hands.
About the Author
